Summary
Machine-generated summaryGłówny Inspektorat Farmaceutyczny, based at ul. Senatorska 12 in Warsaw, Poland, published a call for tenders for services. The contract was a framework agreement covering testing for the quality assessment of immunological medicinal products and products showing biological activity. The work was to run in 2026, 2027 and 2028, meaning 24 months from the date the contract was awarded, and the buyer was the central government administration body itself. The tender was included in the procurement plan under item 1.3.3. The bidding closed, with the deadline for bids set at 2026-07-20.
Description
Official source
Source: Biuletyn Zamówień Publicznych (e-Zamówienia, UZP)
Always verify details on the official notice.
Report an error in this notice
Last verified against Biuletyn Zamówień Publicznych (e-Zamówienia, UZP) 3 months ago
The buyer
Full buyer profileGłówny Inspektorat Farmaceutyczny
- notices in the register
- 9
- awards
- 5
- awarded in total
- €1.7M
One dot per award, on the day it was signed, sized by its value. A ring is an award with no published value.
Recent awards
- Przeprowadzanie w 2026 r., 2027 r., 2028 r. (24 miesiące od daty udzielenia zamówienia) badań w zakresie oceny jakości produktów leczniczych immunologicznych oraz wykazujących aktywność biologiczną
- Usługi doradcze w zakresie programowania oprogramowania - Świadczenie usług asysty, wsparcia technicznego dla Systemu Finansowo-Kadrowego przez okres 24 miesięcy wraz z udzieleniem w tym okresie licencji/sublicencji.
- Laboratoryjne usługi badawcze - Badania jakościowe produktów leczniczych oraz substancji czynnych w 2026r.
Market context
- open now in Research & development
- 438
- median open notice
- €293,131
Who wins in this market
Many suppliersPoland · Research & development
- different companies won awards here
- 220
- of the awards went to the three most frequent winners
- 6%
- buyers awarded contracts here
- 134
Based on 284 awards with a named winner over the last 3 years. Counted by award, not by value, because lot and framework amounts are not comparable. Concentrated means the three most frequent winners took 65% or more of the awards; many suppliers, under 35% with at least ten different winners.
Competition
- tenders per lot on average (open and restricted procedures)
- 2.3
- of those lots received a single tender
- 33%
- of the awards went to companies based in another country
- 6%
- of the tenders came from another country
- 6%
As the official award notices state them, over the last 3 years. Tenders per lot count open and restricted procedures only: in a negotiated procedure or a direct award a single tender is the procedure itself. The country is the one the notice gives for the winner.
Similar tenders
Open now
Awarded before
Never miss a tender like this
46 new notices in Research & development in Poland in the last 7 days. Get an email when new ones appear. Free.
Set up my alertOr follow just its CPV code, Research laboratory services: an email when new tenders arrive under it, no account needed.